AKT1 and cancer: Notch3, a type of Notch receptor (Notch1, Notch2, Notch3, and Notch4), plays an important role in promoting ovarian tumorigenesis, cancer progression, and chemotherapy resistance via activating the PI3K/Akt/mTOR signaling pathway [4].